GTBP — GT Biopharma, Inc.

GTBPGT Biopharma, Inc.

NAS · US · Healthcare · Biotechnology · gtbiopharma.com

0.3931USD-10.66%Mkt Cap: 14.30M USDP/E: —Last update: 2026-05-26

GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Enga…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap14.30M USD

Enterprise Value6.69M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-28.35M USD

Revenue/Share—

Last Price0.3931 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-0.04

PEG1.05

EV/EBITDA—

EV/Revenue—

P/S—

P/B2.01

EPS (TTM)-6.46

EPS (Forward)-10.80

52W Range

0.26104% of range3.850

52W High3.850 USD

52W Low0.2610 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-489.96%

ROA-349.79%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-12.91M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-70.11%

Net Debt-8.92M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity—

Current Ratio4.14

Quick Ratio3.69

Book Value/Sh0.2150 USD

Cash/Share0.2470 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateAug 21, 2017

Splits

Last Split1:30

Split DateFeb 5, 2024

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)3.000 USD

Target Range3.000 USD – 3.000 USD

# Analysts1

Ownership

Shares Out.35.62M

Float33.17M

Insiders3.42%

Institutions6.87%

Short Interest

Short Ratio1.0d

Short % Float1.70%

Short % Out.1.70%

Shares Short604.56K

Short (prev mo.)747.38K

Technical

SMA 500.3918 (+0.3%)

SMA 2000.6685 (-41.2%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)1.55M

Avg Vol (10d)2.95M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—